Anuh Pharma shareholders have approved key leadership and governance decisions at the 65th Annual General Meeting. Mr. Bharat Nemchand Shah and Mr. Gaurav Satish Shah were reappointed as Non-Executive Non-Independent Directors. The company also reappointed Mr. Ankit Kishor Chande as Cost Auditor for the financial year 2025-26 and appointed M/s. GHV & Co. as Secretarial Auditors for a five-year term. Crucially, Mr. Ritesh Shah and Mr. Vivek Shah were reappointed as Joint Managing Directors for a five-year period starting January 2026. These approvals ensure continuity in leadership and strengthen the company's oversight structure.